Englander Institute for Precision Medicine

Publications

Found 805 results
Author Title Type [ Year(Asc)]
2021
Davis MB.  2021.  Genomics and Cancer Disparities: The Justice and Power of Inclusion.. Cancer Discov. 11(4):805-809.
Suhre K, Sarwath H, Engelke R, Sohail MUmar, Cho SJung, Whalen W, Alvarez-Mulett S, Krumsiek J, Choi AMK, Schmidt F.  2021.  Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies.. Front Immunol. 12:781100.
Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, Tang X, Yaron TM, Zhang T, Uhl S et al..  2021.  Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.. Nature. 589(7841):270-275.
Moslehi J, Lichtman AH, Sharpe AH, Galluzzi L, Kitsis RN.  2021.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.. J Clin Invest. 131(5)
Fornarini G, Rebuzzi SE, Banna GL, Calabrò F, Scandurra G, De Giorgi U, Masini C, Baldessari C, Naglieri E, Caserta C et al..  2021.  Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort.. ESMO Open. 6(3):100118.
Sato A, Buqué A, Yamazaki T, Bloy N, Petroni G, Galluzzi L.  2021.  Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells.. STAR Protoc. 2(2):100488.
Petroni G, Kroemer G, Galluzzi L.  2021.  Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy.. Trends Cancer. 7(3):179-181.
De Martino M, Vanpouille-Box C, Galluzzi L.  2021.  Immunological barriers to immunotherapy in primary and metastatic breast cancer.. EMBO Mol Med. 13(8):e14393.
Fucikova J, Coosemans A, Orsulic S, Cibula D, Vergote I, Galluzzi L, Spisek R.  2021.  Immunological configuration of ovarian carcinoma: features and impact on disease outcome.. J Immunother Cancer. 9(10)
Galluzzi L, Garg AD.  2021.  Immunology of Cell Death in Cancer Immunotherapy.. Cells. 10(5)
Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L.  2021.  Immunomodulation by targeted anticancer agents.. Cancer Cell. 39(3):310-345.
Tombal B, Stenzl A, Cella D, Loriot Y, Armstrong AJ, Fizazi K, Beer T, Sternberg CN, Hussain M, Ivanescu C et al..  2021.  The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials.. Cancers (Basel). 13(23)
Petroni G, Galluzzi L.  2021.  Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents.. Oncoimmunology. 10(1):1889101.
Zoughbi WAl, Kim D, Alperstein SAnn, Ohara K, Manohar J, Greco N, Khani F, Robinson BD, Rao RA, Elemento O et al..  2021.  Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.. Cancer Cytopathol. 129(11):874-883.
Ciccolella S, Ricketts C, Gomez MSoto, Patterson M, Silverbush D, Bonizzoni P, Hajirasouliha I, Vedova GDella.  2021.  Inferring cancer progression from Single-Cell Sequencing while allowing mutation losses.. Bioinformatics. 37(3):326-333.
Beg S, Bareja R, Ohara K, Eng KWha, Wilkes DC, Pisapia DJ, Zoughbi WAl, Kudman S, Zhang W, Rao R et al..  2021.  Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.. Transl Oncol. 14(1):100944.
Vitale I, Shema E, Loi S, Galluzzi L.  2021.  Intratumoral heterogeneity in cancer progression and response to immunotherapy.. Nat Med. 27(2):212-224.
Sweeney C, Bracarda S, Sternberg CN, Chi KN, Olmos D, Sandhu S, Massard C, Matsubara N, Alekseev B, Parnis F et al..  2021.  Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial.. Lancet. 398(10295):131-142.
Buqué A, Galluzzi L, Kroemer G.  2021.  Ketosis versus carbotoxicity - metabolism determines the outcome of cancer immunotherapy.. Mol Cell Oncol. 8(1):1868266.
Marderstein AR, Davenport ER, Kulm S, Van Hout CV, Elemento O, Clark AG.  2021.  Leveraging phenotypic variability to identify genetic interactions in human phenotypes.. Am J Hum Genet. 108(1):49-67.
Kaya C, Dorsaint P, Mercurio S, Campbell AM, Eng KWha, Nikiforova MN, Elemento O, Nikiforov YE, Sboner A.  2021.  Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.. Thyroid. 31(4):589-595.
Sheffield NC, Stolarczyk M, Reuter VP, Rendeiro AF.  2021.  Linking big biomedical datasets to modular analysis with Portable Encapsulated Projects.. Gigascience. 10(12)
Yamazaki T, Wennerberg E, Hensler M, Buqué A, Kraynak J, Fucikova J, Zhou XKathy, Sveinbjørnsson B, Rekdal Ø, Demaria S et al..  2021.  LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells.. Oncoimmunology. 10(1):1962592.
Rendeiro AF, Vorkas CKyriakos, Krumsiek J, Singh HK, Kapadia SN, Cappelli LVincenzo, Cacciapuoti MTeresa, Inghirami G, Elemento O, Salvatore M.  2021.  Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment.. Front Immunol. 12:809937.
Zacharias HU, Hertel J, Johar H, Pietzner M, Lukaschek K, Atasoy S, Kunze S, Völzke H, Nauck M, Friedrich N et al..  2021.  A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression.. Mol Psychiatry. 26(12):7372-7383.